Identification of sequence polymorphisms in the D-loop region of mitochondrial DNA as risk biomarkers for malignant fibrous histiocytoma

Mitochondrial DNA

Volumn 26, Issue 3, 2015, Pages 380-383

  Xun, Jianjun ^a   Li, Zhenxing ^a   Song, Xiaolei ^a   Wang, Xueshi ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

D loop; Malignant fibrous histiocytoma; MtDNA; SNP

Indexed keywords

BIOLOGICAL MARKER; MITOCHONDRIAL DNA; TUMOR MARKER;

ADULT; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENE INSERTION; GENETIC MARKER; GENETIC RISK; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; MIDDLE AGED; MITOCHONDRIAL DNA D LOOP SEQUENCE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; GENETICS; METABOLISM; PATHOLOGY; SOFT TISSUE TUMOR;

BIOMARKERS, TUMOR; DNA, MITOCHONDRIAL; FEMALE; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; SOFT TISSUE NEOPLASMS;

EID: 84930910398     PISSN: 19401736     EISSN: 19401744     Source Type: Journal    
DOI: 10.3109/19401736.2013.836510     Document Type: Article

References (43)

1. Al-Agha OM, Igbokwe AA. (2008). Malignant fibrous histiocytoma: between the past and the present. Arch Pathol Lab Med 132:1030-5.
2. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, Eperon IC, et al. (1981). Sequence and organization of the human mitochondrial genome. Nature 290:457-65.
3. Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ. (2007). Mitochondrial genetic background modifies breast cancer risk. Cancer Res 67: 4687-94.
4. Bandy B, Davision AJ. (1990). Mitochondrial mutations may increase oxidative stress: Implications for carcinogenesis and aging? Free Radic Biol Med 8:523-39.
5. Chatterjee A, Mambo E, Sidransky D. (2006). Mitochondrial DNA mutations in human cancer. Oncogene 25:4663-74.
6. Clayton DA. (1991). Replication and transcription of vertebrate mitochondrial DNA. Annu Rev Cell Biol 7:453-78.
7. Cui H, Huang P, Wang Z, Zhang Y, Zhang Z, Xu W, Wang X, et al. (2013). Association of decreased mitochondrial DNA content with the progression of colorectal cancer. BMC Cancer 13:110.
8. Ding C, Li R, Wang P, Jin P, Li S, Guo Z. (2012). Identification of sequence polymorphisms in the D-loop region of mitochondrial DNA as a risk factor for lung cancer. Mitochondrial DNA 23:251-4.
9. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J, Sidransky D. (2000). Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287:2017-19.
10. Gille JJ, Joenje H. (1992). Cell culture models for oxidative stress: Superoxide and hydrogen peroxidative versus normobaric heperoxia. Mutat Res 275:405-14.
11. Ha PK, Tong BC, Westra WH, Sanchez-Cespedes M, Parrella P, Zahurak M, Sidransky D, et al. (2002). Mitochondrial C-tract alteration in premalignant lesions of the head and neck: A marker for progression and clonal proliferation. Clin Cancer Res 8:2260-5.
12. Hibi K, Nakayama H, Yamazaki T, Takase T, Taguchi M, Kasai Y, Ito K, et al. (2001a). Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients. Int J Cancer 94:429-31.
13. Hibi K, Nakayama H, Yamazaki T, Takase T, Taguchi M, Kasai Y, Ito K, et al. (2001b). Mitochondrial DNA alteration in esophageal cancer. Int J Cancer 92:319-21.
14. Hoki Y, Hiraku Y, Ma N, Murata M, Matsumine A, Nagahama M, Shintani K, et al. (2007). iNOS-dependent DNA damage in patients with malignant fibrous histiocytoma in relation to prognosis. Cancer Sci 98:163-8.
15. Jeronimo C, Nomoto S, Caballero OL, Usadel H, Henrique R, Varzim G, Oliveira J, et al. (2001). Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 20:5195-8.
16. Kim MS, Cho WH, Song WS. (2007). Prognostic significance of Ezrin expression in pleomorphic malignant fibrous histiocytoma. Anticancer Res 27:1171-8.
17. Kirches E, Krause G, Warich-Kirches M, Weis S, Schneider T, Meyer-Puttlitz B, Mawrin C, Dietzmann K. (2001). High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int J Cancer 93: 534-8.
18. Kulawiec M, Arnouk H, Desouki MM, Kazim L, Still I, Singh KK. (2006). Proteomic analysis of proteins involved in mitochondria-tonucleus retrograde response in human cancer cells. Cancer Biol Ther 8: 967-75.
19. Lee HC, Li SH, Lin JC, Wu CC, Yeh DC, Wei YH. (2004). Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat Res 547:71-8.
20. Lievre A, Chapusot C, Bouvier AM, Zinzindohoue F, Piard F, Roignot P, Arnould L, et al. (2005). Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol 23:3517-25.
21. Liu VW, Shi HH, Cheung AN, Chiu PM, Leung TW, Nagley P, Wong LC, Ngan HY. (2001). High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res 61:5998-6001.
22. Maximo V, Soares P, Machado JC, Seruca R, Sobrinho-Simoes M. (2000). Mitochondrial DNA alteration in gastric cancer. Gastroenterology 119:1808-9.
23. Navaglia F, Basso D, Fogar P, Sperti C, Greco E, Zambon CF, Stranges A, et al. (2006). Mitochondrial DNA D-loop in pancreatic cancer: Somatic mutations are epiphenomena while the germline 16,519T variant worsens metabolism and outcome. Am J Clin Pathol 126: 593-601.
24. Nomoto S, Yamashita K, Koshikawa K, Nakao A, Sidransky D. (2002). Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma. Clin Cancer Res 8:481-7.
25. O'Brien JE, Stout AP. (1964). Malignant fibrous xanthomas. Cancer 17: 1445-55.
26. Ozzello L, Stout AP, Murray MR. (1963). Cultural characteristics of malignant histiocytomas and fibrous xanthomas. Cancer 16:331-44.
27. Parrella P, Seripa D, Matera MG, Rabitti C, Rinaldi M, Mazzarelli P, Gravina C, et al. (2003). Mutations of the D310 mitochondrial mononucleotide repeat in primary tumors and cytological specimens. Cancer Lett 190:73-7.
28. Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M, Nicol T, et al. (2001). Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res 61: 7623-6.
29. Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, Trush MA, et al. (1998). Somatic mutations of the mitochondrial genome in human colorectal tumors. Nat Genet 20:291-3.
30. Richard SM, Bailliet G, Paez GL, Bianchi MS, Peltomaki P, Bianchi NO. (2000). Nuclear and mitochondrial instability in human breast cancer. Cancer Res 60:4231-7.
31. Sanchez-Cespedes M, Parrella P, Nomoto S, Cohen D, Xiao Y, Esteller M, Jeronimo C, et al. (2001). Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res 61:7015-19.
32. Singh KK, Kulawiec M, Still I, Desouki MM, Geradts J, Matsui S. (2005). Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. Gene 354:140-6.
33. Wanebo HJ, Koness RJ, MacFarlane JK, Eilber FR, Byers RM, Elias EG, Spiro RH, et al. (1992). Head and neck sarcoma: Report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research. Head Neck 14:1-7.
34. Wang L, Bamlet WR, de Andrade M, Boardman LA, Cunningham JM, Thibodeau SN, Petersen GM. (2007). Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev 16:1455-9.
35. Wang L, McDonnell SK, Hebbring SJ, Cunningham JM, St Sauver J, Cerhan JR, Isaya G, et al. (2008). Polymorphisms in mitochondrial genes and prostate cancer risk. Cancer Epidemiol Biomark Prev 17: 3558-66.
36. Warburg O. (1956). On the origin of cancer cells. Science 123:309-14.
37. Weiss MD, Sharon W, Enzinger FM. (1978). Malignant fibrous histiocytoma: An analysis of 200 cases. Cancer 41:2250-66.
38. Weiss SW, Goldbum JR. (2002). Enzinger and Weiss's soft tissue tumors. 4th ed. St. Louis: Mosby.
39. Xie H, Lev D, Gong Y, Wang S, Pollock RK, Wu X, Gu J, et al. (2013). Reduced mitochondrial DNA copy number in peripheral blood leukocytes increases the risk of soft tissue sarcoma. Carcinogenesis 34:1039-43.
40. Xing J, Chen M, Wood CG, Lin J, Spitz MR, Ma J, Amos CI, et al. (2008). Mitochondrial DNA content: Its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst 100:1104-12.
41. Ye C, Shu X, Pierce L, Wen W, Courtney R. (2010). Mutations in the mitochondrial DNA D-loop region and breast cancer risk. Breast Cancer Res Treat 119:431-6.
42. Yeh JJ, Lunetta KL, van Orsouw NJ, Moore Jr FD, Mutter GL, Vijg J, Dahia PL, Eng C. (2000). Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumors. Oncogene 19: 2060-6.
43. Zhang R, Wang R, Zhang F, Wu CH, Fan H, Li Y, Wang C, Guo Z. (2010). Single nucleotide polymorphisms in the mitochondrial displacement loop and outcome of esophageal squamous cell carcinoma. Cancer Res 29:155.